BDKRB1 and malignant colon neoplasm: In addition, Lys‐des‐Arg9‐BK can effectively repair the epithelial mucosal barrier damage caused by colitis, maintain intestinal homeostasis, and reduce the incidence of colitis‐related colon cancer and APC‐deficient adenoma carcinoma by binding to B1R.